Socio-Economic Considerations in Biotechnology Regulation
Springer New York
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
| Chapter title |
Assessing the SEC Landscape and Moving Forward
|
|---|---|
| Chapter number | 20 |
| Book title |
Socio-Economic Considerations in Biotechnology Regulation
|
| Published in |
Socio-economic considerations in biotechnology regulation, December 2013
|
| DOI | 10.1007/978-1-4614-9440-9_20 |
| Book ISBNs |
978-1-4614-9439-3, 978-1-4614-9440-9
|
| Authors |
Karinne Ludlow, Stuart J. Smyth, José Falck-Zepeda, Ludlow, Karinne, Smyth, Stuart J., Falck-Zepeda, José |
| Editors |
Karinne Ludlow, Stuart J. Smyth, José Falck-Zepeda |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 40% |
| Unknown | 3 | 60% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 2 | 40% |
| Student > Bachelor | 1 | 20% |
| Researcher | 1 | 20% |
| Student > Master | 1 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Social Sciences | 3 | 60% |
| Economics, Econometrics and Finance | 1 | 20% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 20% |